MAPK14 and Alzheimer disease: Mitogen-activated protein kinase 14 (MAPK14), a modulator of the innate immune system, has been found significantly upregulated in a mouse model of AD, leading to the increased BACE1 levels and plaque formation (Alam and Scheper, 2016).